Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.13 | 0.7 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.7 |
mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |